imagem de perfil
very good min young, away with the chip shop, means only Ärger❤️
imagem de perfil
@juliana-investment Where do you see a problem with Novo?
imagem de perfil
@Maxxey I currently see several risks for Novo Nordisk: The stock is heavily dependent on the success of a few drugs, competition in the GLP-1 market is extremely fierce, analysts have adjusted price targets downwards and there are legal/regulatory risks. Concentration risk & patent risk
A large part of the revenue comes from active ingredients whose patent protection will expire in the next few years and growth forecasts have been lowered. Think the biggest problem will be illy and Trump